Microsure, an Eindhoven, The Netherlands-based robot-assisted microsurgery company, raised €38M in Series B2 funding.
The round saw participation from European Innovation Council Fund, kineo, Invest-NL, Innovation Industries, BOM Ventures, Ten Cate Investerings Maatschappij, Venturing Tech, Eindhoven University of Technology (TU/e), and Microsure Founders. As part of this financing round, Kreske Nickelsen from new investor kineo will join the supervisory board, further strengthening Microsure’s governance.
The company intends to use the funds to finalize the development of its newest microsurgical robot MUSA-3 for clinical studies, followed by FDA clearance in the USA and CE-mark in Europe.
Led by CEO Sjaak Deckers, Microsure is a medical technology company that specializes in the development of robotic systems that redefine precision, versatility, and efficiency in surgical procedures. MUSA-3, the company’s product under development, is designed in close cooperation with microsurgeons and engineers, specifically for microsurgical applications. MUSA-3 provides precision for microsurgeons, enabling new interventions that are currently virtually impossible to perform by hand.
Founded in 2016 by Eindhoven University of Technology TU/e and Maastricht University Medical Center, the company currently employs over 30 technical professionals.
FinSMEs
04/10/2023